These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7696219)
1. Design of the hapten for the induction of antibodies catalyzing aldol reaction. Teraishi K; Saito M; Fujii I; Nakamura H J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219 [TBL] [Abstract][Full Text] [Related]
2. Antibody catalysis via strategic use of haptenic charge. Kikuchi K; Hilvert D Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376 [TBL] [Abstract][Full Text] [Related]
4. Toward the antibody-catalyzed chemiluminescence. Design and synthesis of hapten. Sawa M; Imaeda Y; Hiratake J; Fujii R; Umeshita R; Watanabe M; Kondo H; Oda J Bioorg Med Chem Lett; 1998 Mar; 8(6):647-52. PubMed ID: 9871576 [TBL] [Abstract][Full Text] [Related]
5. Critical analysis of antibody catalysis. Hilvert D Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475 [TBL] [Abstract][Full Text] [Related]
6. Structural basis for antibody catalysis of a disfavored ring closure reaction. Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817 [TBL] [Abstract][Full Text] [Related]
7. Hapten design for the generation of catalytic antibodies. Thomas NR Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348 [TBL] [Abstract][Full Text] [Related]
9. Large rate accelerations in antibody catalysis by strategic use of haptenic charge. Thorn SN; Daniels RG; Auditor MT; Hilvert D Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136 [TBL] [Abstract][Full Text] [Related]
10. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution. Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943 [TBL] [Abstract][Full Text] [Related]
11. Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis. Huang H; Han WG; Noodleman L; Grynszpan F Bioorg Med Chem; 2001 Dec; 9(12):3185-95. PubMed ID: 11711294 [TBL] [Abstract][Full Text] [Related]
12. Structural convergence in the active sites of a family of catalytic antibodies. Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317 [TBL] [Abstract][Full Text] [Related]
13. Design and syntheses of three haptens to generate catalytic antibodies that cleave amide bonds with nucleophilic catalysis. Ersoy O; Fleck R; Blanco MJ; Masamune S Bioorg Med Chem; 1999 Feb; 7(2):279-86. PubMed ID: 10218819 [TBL] [Abstract][Full Text] [Related]
17. Remarkable remote chiral recognition in a reaction mediated by a catalytic antibody. D'Souza LJ; Gigant B; Knossow M; Green BS J Am Chem Soc; 2002 Mar; 124(10):2114-5. PubMed ID: 11878955 [TBL] [Abstract][Full Text] [Related]
18. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination. Wenthur CJ; Cai X; Ellis BA; Janda KD Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828 [TBL] [Abstract][Full Text] [Related]
19. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review. Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447 [TBL] [Abstract][Full Text] [Related]